GO
Loading...

Drug Retail

More

  • Walgreen CEO to retire after Alliance Boots' merger Wednesday, 10 Dec 2014 | 5:06 PM ET

    Dec 10- U.S. drugstore chain operator Walgreen Co said Chief Executive Greg Wasson would retire after the completion of its pending merger with Alliance Boots Holdings Ltd.. Walgreen shares were up 2.1 percent in extended trading. Stefano Pessina, executive chairman of Alliance Boots, would serve as acting CEO, Walgreen said.

  • Intercept CEO: NASH epidemic of liver disease   Friday, 14 Nov 2014 | 3:16 PM ET
    Intercept CEO: NASH epidemic of liver disease

    Intercept Pharmaceuticals CEO Mark Pruzanski, provides insight to his company's efforts to tackle NASH, or nonalcoholic steatohepatitis, saying over 10 percent of the U.S. population is thought to have NASH. Pruzanski also weighs in on being a public company.

  • Lots of risk in biotech: Pro   Monday, 10 Nov 2014 | 2:22 PM ET
    Lots of risk in biotech: Pro

    Discussing warning signs from Dendreon, and other worrisome companies, with Les Funtleyder, E Square Asset Management.

  • Dendreon declares bankruptcy   Monday, 10 Nov 2014 | 2:18 PM ET
    Dendreon declares bankruptcy

    Joseph Pantginis, Roth Capital, has been negative on Dendreon for a long time, ahead of the drugmaker's bankruptcy protection filing.

  • CHICAGO, Nov 6- A Chicago court on Thursday rejected Walgreens' move to block all disclosures of what the drugstore chain deems confidential information in a defamation lawsuit filed by its former chief financial officer. Cook County Circuit Court Judge Franklin Valderrama said Walgreens, the largest U.S. drugstore chain operator, failed to convince him that...

  • CHICAGO, Nov 6- A Chicago court on Thursday rejected Walgreens' move to block disclosures of what the drugstore chain deems confidential information in a defamation lawsuit filed by its former chief financial officer. Cook County Circuit Court Judge Franklin Valderrama said Walgreens, the largest U.S. drugstore chain operator, failed to convince him that all...

  • CHICAGO, Nov 4- CVS Health Corp reported slightly higher-than-expected quarterly results on Tuesday, helped by growth in specialty pharmacy sales and new client additions in its pharmacy benefits business. Net income at CVS, which operates the No. 2 U.S. drugstore chain and a major pharmacy benefits management business, fell to $948 million, or 81 cents per share,...

  • Supermarket sweep: What could lift Kroger shares Monday, 3 Nov 2014 | 12:37 PM ET
    A shopper outside a Kroger supermarket in Peoria, Illinois.

    Kroger has delivered 43 straight quarters of rising sales at stores open at least a year.

  • Apple CEO fires back as retailers block Pay Tuesday, 28 Oct 2014 | 1:11 AM ET

    LAGUNA BEACH, Calif., Oct 27- Apple Inc CEO Tim Cook fired back at CVS and Rite Aid on Monday after the drugstore chains blocked the iPhone maker's mobile payments service, saying there were plenty of other retailers around the world to sign up. It already totes up more transactions than all other "contactless" payment methods combined, Cook said, citing Visa and...

  • CHICAGO, Oct 27- U.S. drugstore chain Rite Aid Corp will ban Apple Inc's new electronic payments service in its 4,572 stores as it commits to joining a consortium of other large retailers developing a rival payments system. The rival system, called Current C, is being developed by Merchants Customer Exchange, a consortium of merchants that includes Rite Aid and...

  • Drugmakers want indemnity   Thursday, 23 Oct 2014 | 1:38 PM ET
    Drugmakers want indemnity

    Drug companies may be looking for legal protection amid a massive demand for Ebola vaccines, reports CNBC's Meg Tirrell.

  • Former Walgreen CFO sues company for defamation Friday, 17 Oct 2014 | 7:59 AM ET

    Walgreen's former CFO sued the drugstore operator, alleging executives defamed him in news reports that blamed him for errors in its forecast.

  • GW Pharma: Focused on epilepsy   Tuesday, 14 Oct 2014 | 5:22 PM ET
    GW Pharma: Focused on epilepsy

    GW Pharma shares are down sharply after a study of its treatment for ulcerative colitis missed its primary endpoint in a mid-stage trial. GW Pharmaceuticals CEO Justin Gover, says the company's main focus is on its product for epilepsy.

  • Cannabis Expo: Pet food & more   Monday, 13 Oct 2014 | 8:57 AM ET
    Cannabis Expo: Pet food & more

    CNBC's Kate Rogers reports from the East Coast Cannabis Business Expo, on one pot entrepreneur taking CBD, which is an extract of the hemp plant, and putting it in pet food.

  • Weed, Inc.: The business of legal marijuana   Thursday, 9 Oct 2014 | 7:00 AM ET
    Weed, Inc.: The business of legal marijuana

    Medical marijuana, which is legal in 23 states and Washington, D.C., and recreational marijuana -- legal in Colorado and Washington State -- bring dispensaries and states healthy revenues, via taxes and fees. Watch a 90-second overview of the business of legal marijuana by the numbers.

  • Oct 8- Canadian pharmacy chain Jean Coutu Group Inc reported a 3 percent rise in quarterly revenue as an increase in the number of franchised stores helped offset the impact of higher sales of generic drugs. Price-controls for generic drugs, aimed at cutting costs for government and private health programs, have also hurt Jean Coutu and rivals such as Shoppers...

  • Jean Coutu's sales rise 3 pct Wednesday, 8 Oct 2014 | 7:20 AM ET

    Oct 8- Canadian pharmacy chain Jean Coutu Group Inc reported higher quarterly sales, helped by demand for generic drugs and the expansion of its network of franchised stores. Net profit fell to C $53.6 million, or 28 Canadian cents per share, in the quarter ended Aug. 30, from C $208.2 million, or 99 Canadian cents per share, a year earlier. The company had reported a gain...

  • Problems for potpreneurs   Wednesday, 24 Sep 2014 | 1:54 PM ET
    Problems for potpreneurs

    CNBC's Kate Rogers reports on the uphill battle facing potpreneurs.

  • Tekmira soars on FDA news   Monday, 22 Sep 2014 | 2:05 PM ET
    Tekmira soars on FDA news

    Tekmira said regulators in the U.S. and Canada authorized use of its experimental drug for Ebola through an expanded access program. CNBC's Meg Tirrell provides insight.

  • High at work   Thursday, 18 Sep 2014 | 1:54 PM ET
    High at work

    A new survey from Mashable finds nearly 10 percent of Americans admit to smoking pot before heading into the office. CNBC's Kate Rogers shares the difficulties in testing employees.